基于放射科医生视角的改良弥散加权磁共振成像模型:在判断晚期高级别浆液性卵巢癌手术可切除性方面表现更优
本研究纳入2个医疗中心2018年12月至2023年5月间184例术前行弥散加权磁共振成像的高级别浆液性卵巢癌患者,由2名放射科医生独立使用纪念斯隆凯特琳癌症中心模型和改良弥散加权磁共振成像模型评估可切除性。改良模型在研究队列、内部验证队列和外部验证队列的曲线下面积分别为0.867、0.806和0.913,评分0至6分者适合初次肿瘤细胞减灭术。
要点
- 改良弥散加权磁共振成像模型评分0至2、3至4、5至6、7至10和≥11分的完全肿瘤细胞减灭率分别为90.3%、66.7%、53.3%、11.8%和0%。
- 纪念斯隆凯特琳癌症中心模型和改良模型均可独立预测手术可切除性,比值比分别为1.825和1.776。
- 作者认为评分0至6分的患者适合初次肿瘤细胞减灭术。
核心结论
- 与纪念斯隆凯特琳癌症中心模型相比,改良弥散加权磁共振成像模型在术前预测晚期高级别浆液性卵巢癌可切除性方面准确性更高。
- 作者认为评分0至6分的患者适合初次肿瘤细胞减灭术。
研究设计与样本
- 本研究纳入184例高级别浆液性卵巢癌患者,均于2018年12月至2023年5月在2个医疗中心术前行弥散加权磁共振成像。
- 患者队列分为研究队列(n=100)、内部验证队列(n=46)和外部验证队列(n=38)。
- 由2名放射科医生独立使用纪念斯隆凯特琳癌症中心模型和改良弥散加权磁共振成像模型进行术前放射学评估。
- 评估卵巢肿瘤在磁共振成像上的形态学特征为肿块型或浸润型,并对原发肿瘤样本进行转录组分析。
- 进行单因素和多因素统计分析。
主要发现
- 在研究队列中,纪念斯隆凯特琳癌症中心模型评分(组内相关系数分别为0.980和0.959,均P<.001)和改良弥散加权磁共振成像模型评分(组内相关系数分别为0.962和0.940,均P<.001)均显示优秀的观察者内和观察者间一致性。
- 纪念斯隆凯特琳癌症中心模型(比值比1.825;95%置信区间1.390-2.395;P<.001)和改良弥散加权磁共振成像模型(比值比1.776;95%置信区间1.410-2.238;P<.001)均可独立预测手术可切除性。
- 改良弥散加权磁共振成像模型在研究队列、内部验证队列和外部验证队列的曲线下面积分别为0.867、0.806和0.913。
- 使用改良弥散加权磁共振成像模型,评分0至2、3至4、5至6、7至10和≥11分的患者完全肿瘤细胞减灭率分别为90.3%、66.7%、53.3%、11.8%和0%。
- 大多数肿瘤细胞减灭不完全的患者为浸润型肿瘤,纪念斯隆凯特琳癌症中心模型和改良弥散加权磁共振成像模型评分均较高。
关键数值与推荐
- 改良弥散加权磁共振成像模型评分0至2分者完全肿瘤细胞减灭率为90.3%。
- 改良弥散加权磁共振成像模型评分3至4分者完全肿瘤细胞减灭率为66.7%。
- 改良弥散加权磁共振成像模型评分5至6分者完全肿瘤细胞减灭率为53.3%。
- 改良弥散加权磁共振成像模型评分7至10分者完全肿瘤细胞减灭率为11.8%。
- 改良弥散加权磁共振成像模型评分≥11分者完全肿瘤细胞减灭率为0%。
临床怎么用
- 作者认为评分0至6分的患者适合初次肿瘤细胞减灭术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Complete resection of all visible lesions during primary debulking surgery is associated with the most favorable prognosis in patients with advanced high-grade serous ovarian cancer. An accurate preoperative assessment of resectability is pivotal for tailored management. OBJECTIVE: This study aimed to assess the potential value of a modified model that integrates the original 8 radiologic criteria of the Memorial Sloan Kettering Cancer Center model with imaging features of the subcapsular or diaphragm and mesenteric lesions depicted on diffusion-weighted magnetic resonance imaging and growth patterns of all lesions for predicting the resectability of advanced high-grade serous ovarian cancer. STUDY DESIGN: This study included 184 patients with high-grade serous ovarian cancer who underwent preoperative diffusion-weighted magnetic resonance imaging between December 2018 and May 2023 at 2 medical centers. The patient cohort was divided into 3 subsets, namely a study cohort (n=100), an internal validation cohort (n=46), and an external validation cohort (n=38). Preoperative radiologic evaluations were independently conducted by 2 radiologists using both the Memorial Sloan Kettering Cancer Center model and the modified diffusion-weighted magnetic resonance imaging-based model. The morphologic characteristics of the ovarian tumors depicted on magnetic resonance imaging were assessed as either mass-like or infiltrative, and transcriptomic analysis of the primary tumor samples was performed. Univariate and multivariate statistical analyses were performed. RESULTS: In the study cohort, both the scores derived using the Memorial Sloan Kettering Cancer Center (intraclass correlation coefficients of 0.980 and 0.959, respectively; both P<.001) and modified diffusion-weighted magnetic resonance imaging-based models (intraclass correlation coefficients of 0.962 and 0.940, respectively; both P<.001) demonstrated excellent intra- and interobserver agreement. The Memorial Sloan Kettering Cancer Center model (odds ratio, 1.825; 95% confidence interval, 1.390-2.395; P<.001) and the modified diffusion-weighted magnetic resonance imaging-based model (odds ratio, 1.776; 95% confidence interval, 1.410-2.238; P<.001) independently predicted surgical resectability. The modified diffusion-weighted magnetic resonance imaging-based model demonstrated improved predictive performance with an area under the curve of 0.867 in the study cohort and 0.806 and 0.913 in the internal and external validation cohorts, respectively. Using the modified diffusion-weighted magnetic resonance imaging-based model, patients with scores of 0 to 2, 3 to 4, 5 to 6, 7 to 10, and ≥11 achieved complete tumor debulking rates of 90.3%, 66.7%, 53.3%, 11.8%, and 0%, respectively. Most patients with incomplete tumor debulking had infiltrative tumors, and both the Memorial Sloan Kettering Cancer Center and the modified diffusion-weighted magnetic resonance imaging-based models yielded higher scores. The molecular differences between the 2 morphologic subtypes were identified. CONCLUSION: When compared with the Memorial Sloan Kettering Cancer Center model, the modified diffusion-weighted magnetic resonance imaging-based model demonstrated enhanced accuracy in the preoperative prediction of resectability for advanced high-grade serous ovarian cancer. Patients with scores of 0 to 6 were eligible for primary debulking surgery.
引用
- Lu J, Guo Q, Zhang Y, et al. A modified diffusion-weighted magnetic resonance imaging-based model from the radiologist's perspective: improved performance in determining the surgical resectability of advanced high-grade serous ovarian cancer. Am J Obstet Gynecol. 2024. PMID: 38432417. doi:10.1016/j.ajog.2024.02.302
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。